IDEX/$IEX
1D1W1MYTD1Y5YMAX
Capital at risk
About IDEX
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. The company generated $3.5 billion in revenue in 2025.
- Ticker
- $IEX
- Sector
- Industrials
- Primary listing
- NYSE
- Employees
- 8,700
- Headquarters
- Northbrook, United States
- Website
- www.idexcorp.com
IDEX Metrics
BasicAdvanced
$16B
32.18
$6.95
0.97
$2.88
1.31%
Price and volume
Market cap
$16B
Beta
0.97
52-week high
$243.80
52-week low
$158.19
Average daily volume
540K
Dividend rate
$2.88
Financial strength
Current ratio
3.049
Quick ratio
2.01
Long term debt to equity
0.464
Total debt to equity
0.464
Dividend payout ratio (TTM)
41.08%
Interest coverage (TTM)
11.84%
Profitability
EBITDA (TTM)
967.7
Gross margin (TTM)
44.73%
Net profit margin (TTM)
14.49%
Operating margin (TTM)
21.13%
Effective tax rate (TTM)
23.78%
Revenue per employee (TTM)
$410,000
Management effectiveness
Return on assets (TTM)
6.84%
Return on equity (TTM)
12.95%
Valuation
Price to earnings (TTM)
32.182
Price to revenue (TTM)
4.655
Price to book
4.13
Price to tangible book (TTM)
-30.71
Price to free cash flow (TTM)
26.016
Free cash flow yield (TTM)
3.84%
Free cash flow per share (TTM)
8.599
Dividend yield (TTM)
1.29%
Forward dividend yield
1.31%
Growth
Revenue change (TTM)
7.32%
Earnings per share change (TTM)
12.48%
3-year revenue growth (CAGR)
2.53%
10-year revenue growth (CAGR)
5.72%
3-year earnings per share growth (CAGR)
-3.44%
10-year earnings per share growth (CAGR)
6.31%
3-year dividend per share growth (CAGR)
5.11%
10-year dividend per share growth (CAGR)
8.11%
What the Analysts think about IDEX
Analyst ratings (Buy, Hold, Sell) for IDEX stock.
Analyst projections of the future price of IDEX stock.
Bulls say / Bears say
IDEX delivered record second-quarter orders of more than $1 billion, up 28% organically, while sales grew 5% organically. Management responded by raising full-year organic growth guidance to 5% to 6% and adjusted EPS guidance to $8.70 to $8.85. (IDEX Corporation)
Health and Science Technologies is benefiting from strong demand linked to AI data centres, semiconductors, space and defence. These markets drove 47% organic order growth in the second quarter, and IDEX is increasing capacity investment to support demand expected in 2027 and beyond. (Reuters, IDEX Corporation)
Operational execution is improving profitability and cash generation. Second-quarter adjusted EBITDA margin rose 70 basis points to 28.1%, operating cash flow reached 140% of net income, and the company returned capital through $77 million of buybacks and $54 million of dividends. (IDEX Corporation)
The growth is concentrated in Health and Science Technologies. In the second quarter, FMT sales rose only 1% organically and FSDP sales fell 1%, with both segments facing margin pressure from an unfavourable mix. (The Motley Fool, Simply Wall St News)
The second-quarter margin improvement was partly helped by IEEPA tariff refunds, which added about 130 basis points to adjusted EBITDA margin and $0.08 to adjusted EPS. Most of that benefit is not a recurring operating gain, so the underlying run rate is weaker than the headline figures suggest. (Simply Wall St News, The Motley Fool)
The shares look expensive relative to the growth rate. A recent analysis put IDEX at about 26 times earnings versus a peer median near 22 times, while consolidated growth is guided at only 5% to 6%, leaving limited room for an earnings or HST-demand disappointment. (Seeking Alpha, Seeking Alpha)
Data summarised monthly by Lightyear AI. Last updated on 21 Sept 2026.
IDEX Financial Performance
Revenues and expenses
IDEX Earnings Performance
Company profitability
Upcoming events
IDEX News
AllArticlesVideos
Funds containing IDEX
AllEURGBPUSD
Fund name | Fund size | $IEX weighting |
|---|---|---|
iShares S&P 500 Industrials Sector€2B7C | €673M | 0.31% |
iShares S&P 500 Industrials Sector£IISU | £578M | 0.31% |
iShares S&P 500 Equal Weight€O4J0 | €4.3B | 0.20% |
iShares S&P 500 Equal Weight£EWSP | £3.7B | 0.20% |
L&G Global Quality Dividends£LDGG | £279M | 0.20% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.